» Articles » PMID: 18579541

The Modified BODE Index: Validation with Mortality in COPD

Overview
Journal Eur Respir J
Specialty Pulmonary Medicine
Date 2008 Jun 27
PMID 18579541
Citations 39
Authors
Affiliations
Soon will be listed here.
Abstract

Peak oxygen uptake (V'(O(2))) remains the gold standard measurement of exercise capacity and has been associated with survival. A modified BODE (body mass index, airflow obstruction, dyspnoea, exercise capacity) index replacing the 6-min walk distance (6MWD) with V'(O(2)) as % predicted (mBODE%) has been developed and found to have excellent correlation with the conventional BODE index. The objectives of the present study were to compare the ability of the conventional BODE and the mBODE% to predict mortality in 444 patients with chronic obstructive pulmonary disease (COPD) followed for a mean+/-SD period of 71+/-34 months. Anthropometrics, spirometry, lung volumes, comorbidity, cardiopulmonary cyclo-ergometry test and 6MWD were determined at entry. The mean BODE indices for the cohort were: BODE 4.1+/-2 and mBODE% 5.5+/-2. Both indices were significantly correlated with mortality. Logistic regression analysis with COPD survival as the dependent variable identified the BODE index, Charlson's and exercise capacity (in W) as variables associated with this outcome. In conclusion, the conventional BODE index, which uses the 6-min walk distance, predicts mortality in chronic obstructive pulmonary disease as well as the modified index using peak oxygen uptake. The results support the use of the simpler index, which includes the 6-min walk distance in the comprehensive evaluation of patients with chronic obstructive pulmonary disease.

Citing Articles

A protein risk score for all-cause and respiratory-specific mortality in non-Hispanic white and African American individuals who smoke.

Moll M, Pratte K, Debban C, Liu C, Belinsky S, Picchi M Sci Rep. 2024; 14(1):20618.

PMID: 39232179 PMC: 11374806. DOI: 10.1038/s41598-024-71714-7.


Prevalence and clinical characteristics of Sarcopenia in older adult patients with stable chronic obstructive pulmonary disease: a cross-sectional and follow-up study.

Kim S, Hong C, Shin M, Kim K, Park T, Park J BMC Pulm Med. 2024; 24(1):219.

PMID: 38698380 PMC: 11067242. DOI: 10.1186/s12890-024-03034-5.


Genetically Predicted Body Mass Index and Mortality in Chronic Obstructive Pulmonary Disease.

Zhang J, Moll M, Hobbs B, Bakke P, Regan E, Xu H Am J Respir Crit Care Med. 2024; 210(7):890-899.

PMID: 38471013 PMC: 11506912. DOI: 10.1164/rccm.202308-1384OC.


Influence of physical activity on the prognosis of COPD patients: the HADO.2 score - health, activity, dyspnoea and obstruction.

Esteban C, Aguirre N, Aramburu A, Moraza J, Chasco L, Aburto M ERJ Open Res. 2024; 10(1).

PMID: 38226063 PMC: 10789267. DOI: 10.1183/23120541.00488-2023.


Tidal volume expandability and ventilatory efficiency as predictors of mortality in Taiwanese male patients with chronic obstructive pulmonary disease: A 10-year follow-up study - Is V̇O or FEV% the gold standard?.

Chuang M, Wang Y Chron Respir Dis. 2023; 20:14799731231220675.

PMID: 38086393 PMC: 10722945. DOI: 10.1177/14799731231220675.